McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Employees43,000IPOApr 26, 2011SIC5122HQ6555 State Highway 161, Irving, TX, USA, 75039
to
Financials (MXN)
Profitability
Metric
Current
Margins
Gross Margin
3.6%
Operating Margin
1.6%
EBITDA Margin
1.8%
Net Margin
1.2%
OCF Margin
1.5%
FCF Margin
1.3%
Returns on Capital
ROE
—
ROA
5.9%
ROIC
21.0%
ROCE
41.3%
ROC (Greenblatt)
139.8%
3Y ROIIC
22.0%
Consistency
Years Profitable / 10Y
9
Valuation
Metric
Current
Earnings Multiples
P/E (TTM)
20.44
Forward P/E
17.80
P/E ex-NRI
20.08
Shiller P/E (CAPE)
61.11
Cash Flow Multiples
P/FCF
17.90
P/OCF
15.75
P/Owner Earnings
18.78
FCF Yield
5.88%
Enterprise Value Multiples
EV / EBIT
15.20
EV / Forward EBIT
13.66
EV / EBITDA
13.66
EV / Forward EBITDA
12.33
EV / Revenue
0.24
EV / Forward Revenue
0.22
Asset / Sales
P/S
0.24
P/B
—
P/Tangible Book
—
Growth-Adjusted
PEG
—
Capital Returns
Metric
Current
Dividends
Dividend Yield (TTM)
0.43%
Forward Dividend Yield
0.42%
3Y Dividend Growth
14.9%
Payout Ratio
0.08
5Y Yield on Cost
0.82%
Buybacks & Dilution
3Y Buyback Ratio
4.10%
Combined
Shareholder Yield
4.07%
Balance Sheet
Metric
Current
Leverage
Debt / Equity
−3.97
Gross Debt / EBITDA
1.20
Cash / Debt
0.46
Equity / Assets
−0.03
Coverage
Interest Coverage
26.13
Short-Term Liquidity
Current Ratio
0.85
Quick Ratio
0.49
Cash Ratio
0.06
Composite Scores
Piotroski F-Score
6
Altman Z-Score
6.06
Split History
Date
Split
No split history found.
Ex-date
Amount
Pay date
2026-06-01
$0.82
2026-07-01
2026-03-02
$0.82
2026-04-01
2025-12-01
$0.82
2026-01-02
2025-09-02
$0.82
2025-10-01
2025-06-02
$0.71
2025-07-01
2025-03-03
$0.71
2025-04-01
2024-12-02
$0.71
2025-01-02
2024-08-30
$0.71
2024-10-01
2024-06-03
$0.62
2024-07-01
2024-02-29
$0.62
2024-04-01
10 of 157
View allDate
Transcript
Type
2026-08-05
Q1 2027 McKesson Corporation Earnings Conference Call
Earnings Call
2026-08-05
Q1 2027 McKesson Corp Earnings Call Transcript
Earnings Call
2026-05-07
Q4 2026 McKesson Corporation Earnings Conference Call
Earnings Call
2026-05-07
Q4 2026 McKesson Corp Earnings Call Transcript
Earnings Call
2026-03-11
McKesson Corp at Barclays Global Healthcare Conference Transcript
Conference Presentations
2026-03-11
McKesson Corp at Leerink Global Healthcare Conference Transcript
Conference Presentations
2026-02-04
Q3 2026 McKesson Corporation Earnings Conference Call
Earnings Call
2026-02-04
Q3 2026 McKesson Corp Earnings Call Transcript
Earnings Call
2026-01-13
McKesson Corp at JPMorgan Healthcare Conference Transcript
Conference Presentations
2025-12-04
McKesson Corp at Evercore ISI Healthcare Conference Transcript
Conference Presentations
10 of 85
5-Step DuPont Analysis
ROE %
-216.19%
×
×
Net Margin %
1.17%
×
×
Operating Margin %
1.58%
Operating Income
MX$117.73B
÷
Revenue
MX$7.44T
×
Tax Burden
0.7674
Net Income
MX$86.83B
÷
Pretax Income
MX$113.15B
×
Interest Burden
0.9611
Pretax Income
MX$113.15B
÷
Operating Income
MX$117.73B
×
Asset Turnover
5.00
÷
Revenue
MX$7.44T
÷
Average Total Assets
MX$1.49T
Begin Total Assets
MX$1.54T
End Total Assets
MX$1.43T
×
Equity Multiplier
-37.01
÷
Avg Total Assets
MX$1.49T
÷
Avg Stockholders Equity
−MX$40.17B
Begin Equity
−MX$42.61B
End Equity
−MX$37.72B